Ponesimod-d7 (ACT-128800-d7) is the deuterium-labeled form of Ponesimod. It is an effective, selective, and orally active agonist of S1P1, with an IC50 value of 6 nM in radioligand binding assays. Ponesimod-d7 efficiently activates S1P1-mediated signal transduction with an EC50 of 5.7 nM and can prevent lymphocyte-mediated tissue inflammation.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
